SCHEMBL5053196

SCHEMBL5053196

CC(C)CCCCCC1(CCCCCC(C)C)CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
CETP P11597 1/20 0.33
MMP9 P14780 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29465432 1.00 LMNA (0.37) LMNACETPMMP9
SCHEMBL308210 1.00 LMNA (0.37) LMNACETPMMP9
SCHEMBL29372139 0.92 CETP (0.33) LMNACETP
SCHEMBL30368569 0.92 SLC6A4 (0.35) LMNACETP
SCHEMBL18035776 0.85 MMP2 (0.31) LMNAMMP9
SCHEMBL7112064 0.79 CETP (0.35) LMNACETPMMP9
Phthalic Acid SCHEMBL12079410 0.79 CETP (0.44) CETPMMP9
Phthalic Acid SCHEMBL12079605 0.79 CETP (0.44) CETPMMP9
SCHEMBL21244361 0.79 ALDH1A1 (0.33) LMNA
SCHEMBL1298496 0.78 LMNA (0.33) LMNACETPMMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730049-B1 COSMETIC PORTION HENKEL AG & CO KGAA (DE) 2018-09-12 EP disclosed
US-20170273881-A1 COSMETIC COMPOSITION FOR KERATIN FIBRES ALFA PARF GROUP S.P.A. (IT) 2017-09-28 US disclosed
WO-2016026710-A1 COSMETIC COMPOSITION FOR KERATIN FIBRES ALFA PARF GROUP S.P.A. (IT) 2016-02-25 WO disclosed
EP-1567121-B1 NANOPARTICULATE REDISPERSIBLE ZINC-OXIDE POWDER SUS TECH GMBH & CO KG (DE) 2008-03-26 EP disclosed
US-7348029-B2 Surface-modified zinc oxide for the production of nanoparticulate dispersions HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-03-25 US disclosed
US-7225920-B2 Mixing device HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-06-05 US disclosed
EP-1730049-A1 COSMETIC PORTION Henkel Kommanditgesellschaft auf Aktien (DE) 2006-12-13 EP disclosed
EP-1720614-A1 AGENT FOR TREATING KERATIN FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2006-11-15 EP disclosed
EP-1455737-B1 SURFACE MODIFIED ZINC OXIDE FOR THE PRODUCTION OF NANOPARTICULATE DISPERSIONS HENKEL KGAA (DE) 2006-06-07 EP disclosed
CN-1761517-A Mixing device HENKEL KGAA (DE) 2006-04-19 CN disclosed
EP-0868902-B1 Hair dye HENKEL KGAA (DE) 2004-05-12 EP disclosed
US-6613312-B2 Active ingredient such as AZG, silicone and/or hydrocarbon carrier material; a suspending agent or gellant, and dimethicone cross-polymer. UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-09-02 US disclosed
US-20020071817-A1 Antiperspirant products made from wet-milled anhydrous antiperspirant salts HELENE CURTIS 2002-06-13 US disclosed
EP-1201226-A2 Antiperspirant products made from wet-milled anhydrous antiperspirant salts UNILEVER PLC (GB) 2002-05-02 EP disclosed
EP-0914087-B1 USE OF FATS TO REPLACE SILICONE IN THE PRODUCTION OF COSMETIC AND/OR PHARMACEUTICAL PREPARATIONS COGNIS DEUTSCHLAND GMBH (DE) 2002-02-06 EP disclosed
EP-0732912-B1 COSMETIC AND/OR PHARMACEUTICAL PREPARATIONS WITH IMPROVED SKIN FEEL COGNIS DEUTSCHLAND GMBH (DE) 2001-01-17 EP disclosed
EP-0914087-A1 USE OF FATS TO REPLACE SILICONE IN THE PRODUCTION OF COSMETIC AND/OR PHARMACEUTICAL PREPARATIONS Henkel Kommanditgesellschaft auf Aktien (DE) 1999-05-12 EP disclosed
WO-1997047281-A1 USE OF FATS TO REPLACE SILICONE IN THE PRODUCTION OF COSMETIC AND/OR PHARMACEUTICAL PREPARATIONS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1997-12-18 WO disclosed
EP-0332501-B1 Use of polyacrylate polymers as stabilizing agents of dispersions constituted of a water-insoluble phase in an aqueous phase, dispersions obtained, and their preparation PAYOT N G LAB (FR) 1994-05-11 EP disclosed
EP-0332501-A1 Use of polyacrylate polymers as stabilizing agents of dispersions constituted of a water-insoluble phase in an aqueous phase, dispersions obtained, and their preparation LABORATOIRES Dr. N.G. PAYOT (FR) 1989-09-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273881-A1 COSMETIC COMPOSITION FOR KERATIN FIBRES KRT18, GRHPR, CUTA LMNA 697/4885CETP 308/4885MMP9 2738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.